NCT02959463 2026-03-06
Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
University of Pennsylvania
BerGenBio ASA
Aduro Biotech, Inc.
Memorial Sloan Kettering Cancer Center